Melbourne researchers have uncovered genes responsible for the way the body fights infection at the point of ‘invasion’ – whether it’s the skin, liver, lungs or the gut.
Research led by Dr Axel Kallies and Dr Klaas van Gisbergen at the Walter and Eliza Hall Institute of Medical Research, and Dr Laura Mackay from the University of Melbourne at the Peter Doherty Institute for Infection and Immunity has identified the genes Hobit and Blimp1 and found that they control a universal molecular program responsible for placing immune cells at the ‘front lines’ of the body to fight infection and cancer.
The presence of these organ-residing cells, which differ strikingly from their counterparts circulating in the blood stream, is key to local protection against viruses and bacteria.
Walter and Eliza Hall Institute’s Dr Kallies said the human body was fighting disease-causing pathogens every minute of its life. Dr Kallies said identifying how immune cells remain in the part of the body where they are needed most was critical to developing better ways to protect us from infections such as malaria or HIV.
“Discovering these ‘local heroes’ and knowing how the localised immune response is established allows us to find ways to ensure the required cells are positioned where they are needed most,” Dr Kallies said.
“This research will help us understand how immune cells adapt, survive and respond within the organs they protect. This is critical to rid the body of pathogens even before they are established and may also have implications for understanding how the spread of cancer could be prevented.”
The Doherty Institute’s Dr Laura Mackay, who is also an associate investigator with the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, said the factors that control the ‘tissue-residency’ of immune cells – their ability to locally reside in different organs of the body – was previously unknown.
“These results have major implications for developing strategies to induce immune cells in tissues that protect against infectious diseases,” Dr Mackay said.
“It’s a crucial discovery for future vaccine strategies – Hobit and Blimp1 would be key to placing immune cells in the tissues, which we know are really important for protection.”
Learn more: Researchers uncover ‘local heroes’ of immune system
The Latest on: Localised immune response
[google_news title=”” keyword=”Localised immune response” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Localised immune response
- How Is Lyme Disease Treated?on April 27, 2024 at 10:00 am
Lyme disease is a bacterial illness spread by deer ticks. Antibiotics are the primary Lyme disease treatment, but home remedies can help.
- Can nasal Neosporin fight COVID? Surprising new research suggests it workson April 27, 2024 at 2:30 am
A potential treatment for COVID-19 may have been hiding in our medicine cabinets, a new study in PNAS has found ...
- Genetically modified mice reveal key players in immune defense against viruseson April 25, 2024 at 11:00 pm
Chemokines are signaling proteins that orchestrate the interaction of immune cells against pathogens and tumors.
- Newly Discovered Mechanism Explains How Pathogens Avoid the Immune Systemon April 25, 2024 at 8:31 am
The use of the T6SS speargun disrupts the neighboring cell membrane to then enter the cell without activating an immune response. Usually, cells will detect the disrupted cell membrane and alert the ...
- Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meetingon April 25, 2024 at 5:01 am
Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that ...
- Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meetingon April 25, 2024 at 4:00 am
Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care Nal-IRI/5FU/LV arm of the study REHOVOT, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- ("Purple ...
- Gum disease: The silent threat to overall wellnesson April 23, 2024 at 3:45 am
In the world of healthcare, certain connections between what appears to be unrelated conditions continue to surprise researchers and medical professionals. One such connection, gaining increasing ...
- Reprogramming the immune system to attack cancer cellson April 22, 2024 at 11:31 am
Researchers at Virginia Tech's developed a new therapy to target cancer with localized cytokine treatment to boost the immune system.
- Cancer Breakthrough Found to Boost Immune Cells Without Harmful Side-Effects By Directing Protein Cytokineson April 21, 2024 at 7:00 am
A new way to safely boost immune cells to fight cancer—avoiding harmful side-effects such as hair loss—has been developed.
- Researchers develop new method to boost immune cells for fighting canceron April 20, 2024 at 9:23 am
“The whole class of drugs that are employed to jump-start the immune system to fight cancer cells has largely not yet succeeded. Our goal is to create novel solutions that allow researchers to test ...
via Bing News